Requirement for phosphoinositide 3-kinase p110δ signaling in B cell antigen receptor-mediated antigen presentation

被引:45
|
作者
Al-Alwan, Monther M.
Okkenhaug, Klaus
Vanhaesebroeck, Bart
Hayflick, Joel S.
Marshall, Aaron J.
机构
[1] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0W3, Canada
[2] King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Tumor Immunol Unit, Riyadh 11211, Saudi Arabia
[3] Babraham Inst, Lab Lymphocyte Signalling & Dev, Mol Immunol Programme, Cambridge, England
[4] Ludwig Inst Canc Res, London W1P 8BT, England
[5] UCL, Dept Biochem & Mol Biol, London, England
[6] ICOS, Bothell, WA 98021 USA
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 04期
关键词
D O I
10.4049/jimmunol.178.4.2328
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The BCR serves to both signal cellular activation and enhance uptake and presentation of Ags by B cells; however, the intracellular signaling mechanisms linking the BCR to Ag presentation functions have been controversial. PI3Ks are critical signaling enzymes controlling many cellular processes, with the p110 delta isoform playing a critical role in BCR signaling. In this study, we used pharmacological and genetic approaches to evaluate the role of p110 delta signaling in Ag presentation by primary B lymphocytes. It was found that activation of allogeneic T cells is significantly reduced when B cells are pretreated with global PI3K inhibitors, but was intact when p110 delta signaling was specifically inactivated. In contrast, inactivation of p110 delta significantly impaired the ability of B cells to activate T cells in a BCR-mediated Ag uptake and presentation model. Prestimulation of p110 delta-inactivated B cells with anti-CD40 or LPS could not rescue their BCR-mediated Ag presentation ability to normal levels. p110 delta signaling was required for efficient presentation of either anti-Ig or protein Ag via a lysozyme-specific BCR. p110 delta-inactivated B cells were able to internalize Ag normally, and no defects in association of Ag with lysosome-associated membrane protein 1(+) late endosomes were observed; however, these cells were less effective in forming polarized conjugates with Ag-specific T cells. Our data demonstrate a role for p110 delta signaling in B cell Ag presentation function, implicating 3-phosphoinositides and their targets in the latter stages of this process.
引用
收藏
页码:2328 / 2335
页数:8
相关论文
共 50 条
  • [41] Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
    Kang, S
    Denley, A
    Vanhaesebroeck, B
    Vogt, PK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1289 - 1294
  • [42] A biochemical mechanism for the oncogenic potential of the p110β catalytic subunit of phosphoinositide 3-kinase
    Dbouk, Hashem A.
    Pang, Huan
    Fiser, Andras
    Backer, Jonathan M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (46) : 19897 - 19902
  • [43] Phosphoinositide 3-Kinase p110α Gene Therapy Ameliorates Diabetic Cardiomyopathy in Mice
    Prakoso, Darnel
    De Blasio, Miles J.
    Qin, Chengxue
    Rosli, Sarah
    Kiriazis, Helen
    Qian, Hongwei
    Du, Xiao-Jun
    Weeks, Kate L.
    Gregorevic, Paul
    McMullen, Julie R.
    Ritchie, Rebecca H.
    CIRCULATION, 2016, 134
  • [44] Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation
    Pretorius, Lynette
    Du, Xiao-Jun
    Woodcock, Elizabeth A.
    Kiriazis, Helen
    Lin, Ruby C. Y.
    Marasco, Silvana
    Medcalf, Robert L.
    Ming, Ziqiu
    Head, Geoffrey A.
    Tan, Joon Win
    Cemerlang, Nelly
    Sadoshima, Junichi
    Shioi, Tetsuo
    Izumo, Seigo
    Lukoshkova, Elena V.
    Dart, Anthony M.
    Jennings, Garry L.
    McMullen, Julie R.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (03): : 998 - 1009
  • [45] Expression of Phosphoinositide 3-Kinase p110 and p110 Subunits and PIK3CA Mutation in Patients With Advanced Gastric Carcinoma
    Kim, Kyungeun
    Lee, Hyoun Wook
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (10) : 740 - 748
  • [46] Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic Subunits
    Jiang, Xinnong
    Chen, Sen
    Asara, John M.
    Balk, Steven P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (20) : 14980 - 14989
  • [47] The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ
    Guillermet-Guibert, Julie
    Bjorklof, Katja
    Salpekar, Ashreena
    Gonella, Cristiano
    Ramadani, Faruk
    Bilancio, Antonio
    Meek, Stephen
    Smith, Andrew J. H.
    Okkenhaug, Klaus
    Vanhaesebroeck, Bart
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (24) : 8292 - 8297
  • [48] Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
    Burke, John E.
    Vadas, Oscar
    Berndt, Alex
    Finegan, Tara
    Perisic, Olga
    Williams, Roger L.
    STRUCTURE, 2011, 19 (08) : 1127 - 1137
  • [49] Mouse phosphoinositide 3-Kinase p110α gene:: Cloning, structural organization, and localization to chromosome 3 band B
    Aksoy, IA
    Ramsey, MJ
    Fruman, DA
    Aksoy, S
    Cantley, LC
    Tucker, JD
    Roberts, TM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (02) : 438 - 442
  • [50] Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
    Sujobert, P
    Bardet, V
    Cornillet-Lefebvre, P
    Hayflick, JS
    Prie, N
    Verdier, F
    Vanhaesebroeck, B
    Muller, O
    Pesce, F
    Ifrah, N
    Hunault-Berger, M
    Berthou, C
    Villemagne, B
    Jourdan, E
    Audhuy, B
    Solary, E
    Witz, B
    Harousseau, JL
    Himberlin, C
    Lamy, T
    Lioure, B
    Cahn, JY
    Dreyfus, F
    Mayeux, P
    Lacombe, C
    Bouscary, D
    BLOOD, 2005, 106 (03) : 1063 - 1066